Dr. Keith A. Delman, MD

Dr. Delman practices at Emory University Hospital in Atlanta, Georgia, part of Emory University.

Dr. Delman's NPI, 1124030390, was assigned on August 13, 2006. Dr. Delman graduated from State University of New York at Stony Brook, School of Medicine in 1996. Dr. Delman holds Georgia license 056424.

Dr. Delman's primary practice is Emory University Hospital, at 1364 Clifton Road, NE, Atlanta, GA 30322 in De Kalb County. The practice phone is (404) 686-8500.

Dr. Delman's primary practice is Emory University Hospital in Atlanta, Georgia, part of Emory University. Dr. Delman is also affiliated with Emory University Hospital Midtown. The medical group on file is Emory Clinic. Dmand AI also links Dr. Delman to 1 more ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delman practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Delman's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Delman is licensed in Georgia.

CMS data shows 114 Medicare services from Dr. Delman across 4 procedure codes in 2024, for 86 Medicare patients. Medicare paid $5,765 for them. Every service was in an office.

CMS counts 86 Medicare patients who saw Dr. Delman in 2024. The largest group is 65 to 74, with 40 patients. 73% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delman's median patient age at 71, with 40% women.

In 2024, Dr. Delman wrote 41 Medicare Part D claims for 29 patients. 100% of them were for generic drugs. CMS names the drug for 24 of them, across 1 drug with 11 or more claims each, at $39 in total drug cost. In 2023, CMS named 26 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Delman for performance year 2024, reported through an alternative payment model (APM). Dr. Delman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 104 papers to Dr. Delman, published from 2010 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Melanoma, Skin Neoplasms and Lymph Node Excision. Dr. Delman has published most often in Ann Surg Oncol. Dr. Delman's most frequent co-authors are Clara Rose Farley, MD, Jonathan S. Zager, MD and David H. Lawson, MD.

CMS Open Payments shows 7 general payments to Dr. Delman from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Aadi Bioscience, Inc. paid the most, $104.

Dr. Delman graduated from State University of New York at Stony Brook, School of Medicine in 1996.